Exercise program aims to ease side effects of breast cancer treatment
NCT ID NCT07215364
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study looks at whether a 6-month exercise program combining strength and aerobic training can improve quality of life for women with early-stage breast cancer who are taking hormone therapy. About 74 participants in Spain will be split into two groups: one that follows the exercise program and one that receives standard care with exercise guidelines. The goal is to see if exercise helps reduce symptoms related to hormone therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Quirón Sagrado Corazón de Sevilla
Seville, 41013, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Clínico San Cecilio
Granada, 18016, Spain
-
Hospital Universitario de Navarra
Pamplona, Navarre, 31008, Spain
-
Institut Català d'Oncología (ICO) L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
Conditions
Explore the condition pages connected to this study.